PubMed Health⌕ Search

Biomedical subjects

Dmitry Filimonov

Publications and source records attributed to Dmitry Filimonov.

2 recordsLinked to original sources

Prediction of protein functional specificity without an alignment.

We propose a new approach to predict functional specificity of proteins from their amino acid sequences. Our approach is based on two things: structural Multilevel Neighborhoods of Atom (MNA) descriptors and an original Bayesian algorithm. Usually, a protein sequence is presented as a string of amino acid symbols. Here we introduce a new description of an amino acid sequence: a set of structural MNA descriptors. The MNA descriptor is a string describing an atom and its neighbor atoms according to the selected level. In this work, we also use description of a protein sequence as a set of peptides (strings of amino acid symbols). We performed a case study on two subsubclasses of enzyme nomenclature (EC). It is shown that B-statistics give a sufficient predictive power of enzyme specificity prediction for both MNA descriptors and peptides. We also showed that MNA descriptors give higher accuracy values in comparison with peptides and also provide a choice of MNA descriptor levels for best accuracy prediction. The highest average accuracy prediction that was achieved was 0.98.

Amino Acid Sequence↗

Why relevant chemical information cannot be exchanged without disclosing structures.

Both society and industry are interested in increasing the safety of pharmaceuticals. Potentially dangerous compounds could be filtered out at early stages of R&D by computer prediction of biological activity and ADMET characteristics. Accuracy of such predictions strongly depends on the quality & quantity of information contained in a training set. Suggestion that some relevant chemical information can be added to such training sets without disclosing chemical structures was generated at the recent ACS Symposium. We presented arguments that such safety exchange of relevant chemical information is impossible. Any relevant information about chemical structures can be used for search of either a particular compound itself or its close analogues. Risk of identifying such structures is enough to prevent pharma industry from relevant chemical information exchange.

Computer Simulation↗